Posted by Michael Wonder on 24 Mar 2020
Quebec-based pharmaceutical company donates 1 million doses of malaria-drug for COVID-19 patients across Canada
23 March 2020 - Boucherville-based JAMP Pharma is donating one million doses of hydroxychloroquine to hospitals across Canada in the fight against COVID-19.
The drug was designed to treat malaria and patients with certain autoimmune diseases, but is now considered a possible treatment for COVID-19 patients with moderate to severe respiratory distress.
“We’re certainly not trying to suggest it’s a miracle drug,” said managing director for Orimed Pharma and JAMP Group Biosimilars Bruno Mader, since hydroxychloroquine hasn’t yet been approved by Health Canada for this use. One preliminary study of hydroxychloroquine in patients who have contracted the virus is considered promising in the fight against COVID-19.
